Literature DB >> 10874499

Augmentation of host immune responses to cancer: overcoming the barrier of tumor antigen-specific T-cell tolerance.

H I Levitsky1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874499

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  7 in total

1.  T cells take aim at cancer.

Authors:  Drew Pardoll
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 2.  Evaluation of current cancer immunotherapy: hemato-oncology.

Authors:  Christopher S Hourigan; Hyam I Levitsky
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

3.  Identification of endogenous HLA-A2-restricted reactivity against shared melanoma antigens in patients using the quantitative real-time polymerase chain reaction.

Authors:  Stacy E Thurber; Hung T Khong; Udai S Kammula; Steven A Rosenberg
Journal:  J Immunother       Date:  2002 Jan-Feb       Impact factor: 4.456

4.  Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation.

Authors:  Paria Mirmonsef; Gladys Tan; Gang Zhou; Tricia Morino; Kimberly Noonan; Ivan Borrello; Hyam I Levitsky
Journal:  Blood       Date:  2007-12-06       Impact factor: 22.113

5.  Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells.

Authors:  X Zhang; P Zhao; C Kennedy; K Chen; J Wiegand; G Washington; L Marrero; Y Cui
Journal:  Cancer Gene Ther       Date:  2007-12-14       Impact factor: 5.987

6.  Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.

Authors:  Dominik Rüttinger; Natasja K van den Engel; Hauke Winter; Marcus Schlemmer; Heike Pohla; Stefanie Grützner; Beate Wagner; Dolores J Schendel; Bernard A Fox; K-W Jauch; Rudolf A Hatz
Journal:  J Transl Med       Date:  2007-09-14       Impact factor: 5.531

7.  Immunomodulatory effects of hemagglutinin- (HA-) modified A20 B-cell lymphoma expanded as a brain tumor on adoptively transferred HA-Specific CD4+ T cells.

Authors:  Valentin P Shichkin; Roman M Moriev
Journal:  ScientificWorldJournal       Date:  2014-02-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.